Early mild cognitive impairment (early MCI) is a stage on the
continuum from normal cognition to Alzheimer’s Disease. The
Azheimer’s Disease Neuroimaging Initiative (ADNI) GO study
seeks to characterize this stage, and further characterize
the normal and late MCI stages that precede/follow it.
Subjects will be followed longitudinally for 18 months.
Subjects will receive cognitive testing and MRI scans throughout
the course of this study to determine how changes in whole brain
and hippocampus volume correlate with changes in cognition. Please
see the following web site for more details:
www.adcs.org/Studies/ImagineADNI.aspx (external link)
Alzheimer’s Disease Neuroimaging Initiative (ADNI) GO Study
This project was funded by: NIH
The term of this project was: March 2010 to April 2012
The number of subjects scanned during this project was: 15